These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Author: Park SJ, Wu CH, Safa AR.
    Journal: Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586.
    Abstract:
    BACKGROUND: Several mechanisms are known to cause resistance to chemotherapy in cancer cells, but the mechanisms of drug resistance due to a lack of apoptosis are not well elucidated. MATERIALS AND METHODS: To understand the mechanisms of resistance to apoptosis induced by doxorubicin (DOX), we developed a DOX-resistant variant of MCF-7 referred to as MCF-7/Adr-20, measured growth inhibition by methylene blue cell survival assay, quantitated apoptosis by annexin V binding assay and detected activation of caspases-6, -7, -8, -9 and -10 in these cells. RESULTS: The resistant cells expressed 20-fold resistance to apoptosis induced by DOX compared to MCF-7 cells. MCF-7/Adr-20 cells did not express MDR1 mRNA or its product P-glycoprotein and they did not overexpress MRP-1. Treating MCF-7 cells with 0.01, 0.1 and 1 microM DOX for 72 h induced 8, 14 and 28% apoptosis, respectively. However, only 1 microM DOX was able to trigger about 8% apoptosis in MCF- 7/Adr-20 cells. Moreover, apoptosis triggered by 0.01 and 0.1 microM DOX in MCF-7 cells was mainly caspase-dependent, but at 1 microM about 70% of apoptosis was caspase-dependent. Western blot analysis revealed that caspase-7 was activated at 0.1 and 1 microM DOX treatment and caspases-6, -8, -9 and 10 were only activated at 1 microM DOX treatment in MCF-7 cells, but none of the caspases checked were activated in MCF-7/Adr-20 cells. Moreover, DOX at 0.01 and 0.1 microM induced p53 and p21(WAF-1/CIP-1) to the same extent in both MCF-7 and MCF-7/Adr-20 cells. Therefore, while DOX triggers growth arrest and induces p53 and p21(WAF-1/CIP-1) in these cells, defects in activation of the initiator and executioner caspases play a major role in resistance to apoptosis triggered by DOX.
    [Abstract] [Full Text] [Related] [New Search]